Effect of metformin on blood pressure in patients with hypertension: a randomized clinical trial
- 21 August 2018
- journal article
- research article
- Published by Springer Nature in Endocrine
- Vol. 63 (2) , 252-258
Abstract
Part of the beneficial effects of metformin on the prevention of cardiovascular events in diabetes can be attributed to pleiotropic effects, including a blood pressure (BP)-lowering effect. In a double-blind parallel clinical trial (NCT02072382), the effect of metformin on BP evaluated by ambulatory blood pressure monitoring (ABPM) was measured.Keywords
This publication has 44 references indexed in Scilit:
- Effects of lifestyle modification and metformin on atherosclerotic indices among HIV-infected patients with the metabolic syndromeAIDS, 2012
- Effect of metformin on cardiovascular events and mortality: a meta‐analysis of randomized clinical trialsDiabetes, Obesity and Metabolism, 2011
- DURATION-1: Exenatide Once Weekly Produces Sustained Glycemic Control and Weight Loss Over 52 WeeksDiabetes Care, 2010
- VI Diretrizes Brasileiras de HipertensãoArquivos Brasileiros de Cardiologia, 2010
- Cardiovascular Outcomes in Trials of Oral Diabetes MedicationsArchives of internal medicine (1960), 2008
- Metabolic syndrome—a new world‐wide definition. A Consensus Statement from the International Diabetes FederationDiabetic Medicine, 2006
- The effect of metformin on blood pressure, plasma cholesterol and triglycerides in type 2 diabetes mellitus: a systematic reviewJournal of Internal Medicine, 2004
- Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)The Lancet, 1998
- Metabolic and Hemodynamic Effects of Metformin and Glibenclamide in Normotensive NIDDM PatientsDiabetes Care, 1993
- Effects of Metformin on Insulin Resistance, Risk Factors for Cardiovascular Disease, and Plasminogen Activator Inhibitor in NIDDM Subjects: A study of two ethnic groupsDiabetes Care, 1993